104 related articles for article (PubMed ID: 24423775)
1. [Self-controlled case-series (SCCS) method as a tool for the evaluation on the safety of vaccine].
Pan JR; He HQ; Yan R; Fu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Aug; 34(8):836-9. PubMed ID: 24423775
[TBL] [Abstract][Full Text] [Related]
2. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design.
Zeng C; Newcomer SR; Glanz JM; Shoup JA; Daley MF; Hambidge SJ; Xu S
Am J Epidemiol; 2013 Dec; 178(12):1750-9. PubMed ID: 24327463
[TBL] [Abstract][Full Text] [Related]
3. Comparison of epidemiologic methods for active surveillance of vaccine safety.
McClure DL; Glanz JM; Xu S; Hambidge SJ; Mullooly JP; Baggs J
Vaccine; 2008 Jun; 26(26):3341-5. PubMed ID: 18462849
[TBL] [Abstract][Full Text] [Related]
4. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.
Weldeselassie YG; Whitaker HJ; Farrington CP
Epidemiol Infect; 2011 Dec; 139(12):1805-17. PubMed ID: 21849099
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies.
Chen RT
Vaccine; 2004 May; 22(15-16):2047-53. PubMed ID: 15121321
[TBL] [Abstract][Full Text] [Related]
7. The use of relative incidence ratios in self-controlled case series studies: an overview.
Hawken S; Potter BK; Little J; Benchimol EI; Mahmud S; Ducharme R; Wilson K
BMC Med Res Methodol; 2016 Sep; 16(1):126. PubMed ID: 27664070
[TBL] [Abstract][Full Text] [Related]
8. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design.
Xu S; Newcomer S; Nelson J; Qian L; McClure D; Pan Y; Zeng C; Glanz J
Biom J; 2014 May; 56(3):513-25. PubMed ID: 24402780
[TBL] [Abstract][Full Text] [Related]
9. A modified self-controlled case series method to examine association between multidose vaccinations and death.
Kuhnert R; Hecker H; Poethko-Müller C; Schlaud M; Vennemann M; Whitaker HJ; Farrington CP
Stat Med; 2011 Mar; 30(6):666-77. PubMed ID: 21337361
[TBL] [Abstract][Full Text] [Related]
10. Multiple self-controlled case series for large-scale longitudinal observational databases.
Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
[TBL] [Abstract][Full Text] [Related]
11. Relative incidence estimation from case series for vaccine safety evaluation.
Farrington CP
Biometrics; 1995 Mar; 51(1):228-35. PubMed ID: 7766778
[TBL] [Abstract][Full Text] [Related]
12. [Adverse events following immunization and causality assessment of an adverse event following immunization].
Yao KH; Yang YH
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):1-4. PubMed ID: 24461168
[TBL] [Abstract][Full Text] [Related]
13. When should case-only designs be used for safety monitoring of medical products?
Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological designs for vaccine safety assessment: methods and pitfalls.
Andrews N
Biologicals; 2012 Sep; 40(5):389-92. PubMed ID: 21985898
[TBL] [Abstract][Full Text] [Related]
15. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.
Glanz JM; McClure DL; Xu S; Hambidge SJ; Lee M; Kolczak MS; Kleinman K; Mullooly JP; France EK
J Clin Epidemiol; 2006 Aug; 59(8):808-18. PubMed ID: 16828674
[TBL] [Abstract][Full Text] [Related]
16. Comparison design and evaluation power in cohort and self-controlled case series designs for post-authorization vaccine safety studies.
Sato S; Kawazoe Y; Katsuta T; Fukuda H
PeerJ; 2024; 12():e16780. PubMed ID: 38282861
[TBL] [Abstract][Full Text] [Related]
17. A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.
Baker MA; Lieu TA; Li L; Hua W; Qiang Y; Kawai AT; Fireman BH; Martin DB; Nguyen MD
Am J Epidemiol; 2015 Apr; 181(8):608-18. PubMed ID: 25769306
[TBL] [Abstract][Full Text] [Related]
18. Safety and utilization of influenza immunization in children with inflammatory bowel disease.
Benchimol EI; Hawken S; Kwong JC; Wilson K
Pediatrics; 2013 Jun; 131(6):e1811-20. PubMed ID: 23650306
[TBL] [Abstract][Full Text] [Related]
19. Control without separate controls: evaluation of vaccine safety using case-only methods.
Farrington CP
Vaccine; 2004 May; 22(15-16):2064-70. PubMed ID: 15121324
[TBL] [Abstract][Full Text] [Related]
20. Identifying optimal risk windows for self-controlled case series studies of vaccine safety.
Xu S; Zhang L; Nelson JC; Zeng C; Mullooly J; McClure D; Glanz J
Stat Med; 2011 Mar; 30(7):742-52. PubMed ID: 21394750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
